| 1. |
- Dahlqvist Leinhard, Olof, 1978-, et al.
(författare)
-
Body Composition Profiling using MRI - Normative Data for Subjects with Cardiovascular Disease Extracted from the UK Biobank Imaging Cohort
- 2016
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- PURPOSETo describe the distribution of MRI-derived body composition measurements in subjects with cardiovascular disease (CVD) compared to subjects without any history of CVD.METHOD AND MATERIALS1864 males and 2036 females with an age range from 45 to 78 years from the UK Biobank imaging study were included in the study. Visceral adipose tissue volume normalized with height2 (VATi), total abdominal adipose tissue volume normalized with height2 (ATATi), total lean thigh muscle volume normalized with body weight (muscle ratio) and liver proton density fat fraction (PDFF) were measured with a 2-point Dixon imaging protocol covering neck to knee and a 10-point Dixon single slice protocol positioned within the liver using a 1.5T MR-scanner (Siemens, Germany). The MR-images were analyzed using AMRA® Profiler research (AMRA, Sweden). 213 subjects with history of cardiovascular events (angina, heart attack, or stroke) (event group) were age and gender matched to subjects with high blood pressure (HBP group), and subjects without CVD (controls).Kruskal-Wallis and Mann-Whitney U tests were used to test the observed differences for each measurement and group without correction for multiple comparisons.RESULTSVATi in the event group was 1.73 (1.13 - 2.32) l/m2 (median, 25%-75% percentile) compared to 1.68 (1.19 - 2.23) in the HBP group, and 1.30 (0.82-1.87) in the controls. ATATi in the event group was 4.31 (2.90-5.39) l/m2 compared to 4.05 (3.07-5.12) in the HBP group, and 3.48 (2.48-4.61) in the controls. Muscle ratio in the event group was 0.13 (0.12 - 0.15) l/kg as well as in the HBP group, compared to 0.14 (0.12 - 0.15) in the controls. Liver PDFF in the event group was 2.88 (1.77 - 7.72) % compared to 3.44 (2.04-6.18) in the HBP group, and 2.50 (1.58 - 5.15) in the controls. Kruskal-Wallis test showed significant differences for all variables and group comparisons (p<0.007). The post hoc test showed significant differences comparing the controls to both the event group and the HBP group. These were more significant for VATi and ATATi (p<10-4) than for muscle ratio and PDFF (p<0.03). No significant differences were detected between the event group and the HBP group.CONCLUSIONCardiovascular disease is strongly associated with high VATi, liver fat, and ATATi, and with low muscle ratio.CLINICAL RELEVANCE/APPLICATIONThe metabolic syndrome component in CVD can be effectively described using MRI-based body composition profiling.
|
|
| 2. |
- Dahlqvist Leinhard, Olof, 1978-, et al.
(författare)
-
Body Composition Profiling using MRI - Normative Data for Subjects with Diabetes Extracted from the UK Biobank Imaging Cohort
- 2016
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- PURPOSETo describe the distribution of MRI derived body composition measurements in subjects with diabetes mellitus (DM) compared to subjects without diabetes.METHOD AND MATERIALS3900 subjects (1864 males and 2036 females) from the UK Biobank imaging study were included in the study. The age range was 45 to 78 years. Visceral adipose tissue volume normalized with height2 (VATi), total abdominal adipose tissue volume normalized with height2 (ATATi), total lean thigh muscle volume normalized with body weight (muscle ratio) and liver proton density fat fraction (PDFF) were measured with a 6 minutes 2-point Dixon imaging protocol covering neck to knee and a 10-point Dixon single axial slice protocol positioned within the liver using a 1.5T MR-scanner (Siemens, Germany). The MR-images were analyzed using AMRA® Profiler research (AMRA, Sweden). 194 subjects with clinically diagnosed DM (DM group) were age and gender matched to subjects without DM (control group). For each variable and group, the median, 25%-percentile and 75%-percentile was calculated. Mann-Whitney U test was used to test the observed differences.RESULTSVATi in the DM group was 2.13 (1.43-2.62) l/m2 (median, 25% - 75% percentile) compared to 1.32 (0.86 - 1.79) l/m2 in the control group. ATATi in the DM group was 4.94 (3.86-6.19) l/m2 compared to 3.40 (2.56 - 4.70) l/m2 in the control group. Muscle ratio in the DM group was 0.13 (0.11 - 0.14) l/kg compared to 0.14 (0.12 - 0.15) l/kg in the control group. Liver PDFF in the DM group was 7.23 (2.68 - 13.26) % compared to 2.49 (1.53 - 4.73) % in the control group. Mann-Whitney U test detected significant differences between the DM group and the control group for all variables (p<10-5).CONCLUSIONDM is strongly associated with high visceral fat, liver fat, and total abdominal fat, and low muscle ratio.CLINICAL RELEVANCE/APPLICATIONBody composition profiling shows high potential to provide direct biomarkers to improve characterization and early diagnosis of DM.
|
|
| 3. |
- Karlsson, Anette, et al.
(författare)
-
Defining Sarcopenia with MRI - Establishing Threshold Values within a Large-Scale Population Study
- 2016
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- PURPOSETo identify gender specific threshold values for sarcopenia detection for lean thigh muscle tissue volume quantified using MRI.METHOD AND MATERIALSCurrent gender-specific thresholds for sarcopenia detection are based on quantification on appendicular lean tissue normalized with height^2 using DXA (7.26 kg/m2 for men and 5.45 kg/m2 for women). In this study 3514 subjects (1548 males and 1966 females) in the imaging subcohort of UK Biobank with paired DXA and MRI scans were included. The age range was 45 to 78 years. The total lean thigh volume normalized with height2 (TTVi) was determined with a 6 minutes neck to knee 2-point Dixon MRI protocol using a 1.5T MR-scanner (Siemens, Germany) followed by analysis with AMRA® Profiler (AMRA, Sweden). The appendicular lean tissue mass normalized with height2 (ALTMi) was assessed using DXA (GE-Lunar iDXA). Subjects with ALTMi lower than the gender specific threshold were categorized as sarcopenic. Gender specific threshold values were determined for detection of sarcopenic subjects based on TTVi optimizing sensitivity and specificity. Area under receiver operator curve (AUROC) was calculated as well as the linear correlation between TTVi and ALTMi.RESULTSA threshold value of TTVi = 3.64 l/m2 provided a sensitivity and specificity of 0.88 for sarcopenia detection in males. The AUROC was 0.96. Similarly, a TTVi < 2.76 l/m2 identified sarcopenic female subjects with a sensitivity and specificity of 0.89. The corresponding AUROC was 0.96. The linear correlation between TTVi and ALTMi was 0.93 (99%CI: 0.93-0.94).CONCLUSIONMRI-based quantification of total lean thigh volume normalized with height^2 could be used to categorize sarcopenia in the study group. Threshold values are suggested.CLINICAL RELEVANCE/APPLICATIONThe study suggests that sarcopenia can be diagnosed using a rapid MRI scan with high sensitivity and specificity.
|
|
| 4. |
|
|
| 5. |
|
|
| 6. |
- Linge, Jennifer, et al.
(författare)
-
Body Composition Profiling in the UK Biobank Imaging Study
- 2018
-
Ingår i: Obesity. - : WILEY. - 1930-7381 .- 1930-739X. ; 26:11, s. 1785-1795
-
Tidskriftsartikel (refereegranskat)abstract
- ObjectiveMethodsThis study aimed to investigate the value of imaging-based multivariable body composition profiling by describing its association with coronary heart disease (CHD), type 2 diabetes (T2D), and metabolic health on individual and population levels. The first 6,021 participants scanned by UK Biobank were included. Body composition profiles (BCPs) were calculated, including abdominal subcutaneous adipose tissue, visceral adipose tissue (VAT), thigh muscle volume, liver fat, and muscle fat infiltration (MFI), determined using magnetic resonance imaging. Associations between BCP and metabolic status were investigated using matching procedures and multivariable statistical modeling. ResultsConclusionsMatched control analysis showed that higher VAT and MFI were associated with CHD and T2D (Pamp;lt;0.001). Higher liver fat was associated with T2D (Pamp;lt;0.001) and lower liver fat with CHD (Pamp;lt;0.05), matching on VAT. Multivariable modeling showed that lower VAT and MFI were associated with metabolic health (Pamp;lt;0.001), and liver fat was nonsignificant. Associations remained significant adjusting for sex, age, BMI, alcohol, smoking, and physical activity. Body composition profiling enabled an intuitive visualization of body composition and showed the complexity of associations between fat distribution and metabolic status, stressing the importance of a multivariable approach. Different diseases were linked to different BCPs, which could not be described by a single fat compartment alone.
|
|
| 7. |
- Linge, Jennifer, et al.
(författare)
-
Sub-phenotyping Metabolic Disorders Using Body Composition : An Individualized, Nonparametric Approach Utilizing Large Data Sets
- 2019
-
Ingår i: Obesity. - : John Wiley & Sons. - 1930-7381 .- 1930-739X. ; 27:7, s. 1190-1199
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: This study performed individual-centric, data-driven calculations of propensity for coronary heart disease (CHD) and type 2 diabetes (T2D), utilizing magnetic resonance imaging-acquired body composition measurements, for sub-phenotyping of obesity and nonalcoholic fatty liver disease (NAFLD).Methods: A total of 10,019 participants from the UK Biobank imaging substudy were included and analyzed for visceral and abdominal subcutaneous adipose tissue, muscle fat infiltration, and liver fat. An adaption of the k-nearest neighbors algorithm was applied to the imaging variable space to calculate individualized CHD and T2D propensity and explore metabolic sub-phenotyping within obesity and NAFLD.Results: The ranges of CHD and T2D propensity for the whole cohort were 1.3% to 58.0% and 0.6% to 42.0%, respectively. The diagnostic performance, area under the receiver operating characteristic curve (95% CI), using disease propensities for CHD and T2D detection was 0.75 (0.73-0.77) and 0.79 (0.77-0.81). Exploring individualized disease propensity, CHD phenotypes, T2D phenotypes, comorbid phenotypes, and metabolically healthy phenotypes were found within obesity and NAFLD.Conclusions: The adaptive k-nearest neighbors algorithm allowed an individual-centric assessment of each individual’s metabolic phenotype moving beyond discrete categorizations of body composition. Within obesity and NAFLD, this may help in identifying which comorbidities a patient may develop and conse- quently enable optimization of treatment.
|
|
| 8. |
|
|
| 9. |
|
|
| 10. |
- Tejani, Sanaa, et al.
(författare)
-
Cardiometabolic Health Outcomes Associated With Discordant Visceral and Liver Fat Phenotypes: Insights From the Dallas Heart Study and UK Biobank
- 2022
-
Ingår i: Mayo Clinic proceedings. - New York, United States : Elsevier. - 0025-6196 .- 1942-5546. ; 97:2, s. 225-237
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To evaluate the cardiometabolic outcomes associated with discordant visceral adipose tissue (VAT) and liver fat (LF) phenotypes in 2 cohorts.Patients and Methods: Participants in the Dallas Heart Study underwent baseline imaging from January 1, 2000, through December 31, 2002, and were followed for incident cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) through 2013. Associations between VAT-LF groups (low-low, high-low, low-high, and high-high) and outcomes were assessed using multivariable- adjusted regression and were replicated in the independent UK Biobank.Results: The Dallas Heart Study included 2064 participants (mean SD age, 449 years; 54% female; 47% black). High VATehigh LF and high VATelow LF were associated with prevalent atheroscle- rosis, whereas low VATehigh LF was not. Of 1731 participants without CVD/T2DM, 128 (7.4%) developed CVD and 95 (5.5%) T2DM over a median of 12 years. High VATehigh LF and high VATelow LF were associated with increased risk of CVD (hazard ratios [HRs], 2.0 [95% CI, 1.3 to 3.2] and 2.4 [95% CI, 1.4 to 4.1], respectively) and T2DM (odds ratios [ORs], 7.8 [95% CI, 3.8 to 15.8] and 3.3 [95% CI, 1.4 to 7.8], respectively), whereas low VATehigh LF was associated with T2DM (OR, 2.7 [95% CI, 1.1 to 6.7]). In the UK Biobank (N1⁄422,354; April 2014-May 2020), only high VATelow LF remained associated with CVD after multivariable adjustment for age and body mass index (HR, 1.5 [95% CI, 1.2 to 1.9]).Conclusion: Although VAT and LF are each associated with cardiometabolic risk, these observations demonstrate the importance of separating their cardiometabolic implications when there is presence or absence of either or both in an individual.
|
|
